HANA EL SAHLY to Chikungunya Fever
This is a "connection" page, showing publications HANA EL SAHLY has written about Chikungunya Fever.
Connection Strength
0.239
-
A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults. J Infect Dis. 2026 Mar 17; 233(3):e641-e645.
Score: 0.239